Keyphrases
Drug Target
100%
Combination Therapy
100%
Virus Replication
100%
Host Cell
100%
Antiretroviral Agents
100%
Fusion Inhibitor
100%
Adsorption
100%
Strong Reduction
50%
Resistance Development
50%
New Targets
50%
Protease Inhibitors
50%
HIV Patients
50%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
50%
Preventing Infection
50%
Nucleoside Reverse Transcriptase Inhibitors
50%
New Antiretrovirals
50%
Fusion Process
50%
Medicine and Dentistry
Drug Delivery System
100%
Human Immunodeficiency Virus
100%
Virus Replication
100%
Human Immunodeficiency Virus Fusion Inhibitor
100%
Combination Therapy
66%
Host Cell
66%
Antiretrovirus Agent
66%
Infection
33%
Side Effect
33%
Proteinase Inhibitor
33%
Nonnucleoside Reverse Transcriptase Inhibitor
33%
Reverse-Transcriptase Inhibitor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Delivery System
100%
HIV
100%
Human Immunodeficiency Virus Fusion Inhibitor
100%
Combination Therapy
66%
Antiretrovirus Agent
66%
Infection
33%
Side Effect
33%
Proteinase Inhibitor
33%
Nonnucleoside Reverse Transcriptase Inhibitor
33%
RNA Directed DNA Polymerase Inhibitor
33%